Table 2 Summary of patient medical history
From: Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome
| Â | ME/CFS | Controls |
|---|---|---|
Duration of CFS disease (Year) | ||
 1–5 | 28 (17%) | NA |
 6–10 | 30 (18%) | NA |
 11–15 | 22 (13%) | NA |
 16–20 | 20 (12%) | NA |
 21–30 | 34 (21%) | NA |
 31–63 | 26 (16%) | NA |
 Unreported | 4 (2% | NA |
Diagnosed with ME/CFS or experiencing symptoms of ME/CFS | ||
 Yes | 161 (97%) | NA |
 No | NA | 78 (94%) |
 Unreported* | 5 (3%) | 5 (6%) |
Diagnosed with ME/CFS by a Health Care Professional | ||
 Yes | 156 (94%) | NA |
 No | 5 (3%) | NA |
 Unreported* | 5 (3%) | NA |
Severity of ME/CFS symptoms (house-bound or bedridden) | ||
 Yes | 82 (49%) | NA |
 No | 79 (48%) | NA |
 Unreported* | 5 (3%) | NA |
Triggering event leading to ME/CFS symptoms | ||
 Yes | 126 (76%) | NA |
 No | 35 (21%) | NA |
 Unreported* | 5 (3%) | NA |
Triggering events | ||
 Viral, bacterial and/or other unknown infection | 101 (80%) | NA |
 Physical and emotional trauma and others | 25 (20%) | NA |
Diagnosed with any autoimmune diseases | ||
 Yes | 50 (30%) | 8 (10%) |
 No | 110 (66%) | 69 (83%) |
Unreported* | 6 (4%) | 6 (7%) |
Diagnosed with any cancer | ||
 Yes | 21 (13%) | 2 (2%) |
 No | 137 (82%) | 71 (86%) |
 Unreported* | 8 (5%) | 10 (12%) |
Diagnosed with kidney disease | ||
 Yes | 5 (3%) | 0 (0%) |
 No | 154 (93%) | 73 (88%) |
 Unreported* | 7 (4%) | 10 (12%) |